RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer

  • Authors:
    • Jia‑Juan Hsieh
    • Ming‑Mo Hou
    • John Wen‑Cheng Chang
    • Yung‑Chi Shen
    • Hsin‑Yi Cheng
    • Todd Hsu
  • View Affiliations

  • Published online on: June 28, 2019     https://doi.org/10.3892/ol.2019.10547
  • Pages: 2598-2604
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ras‑related protein Rab‑38 (RAB38) is a member of the Ras small G protein family that regulates intracellular vesicular trafficking. Although the expression of RAB38 is reportedly deregulated in several types of cancer, its role in tumor biology remains to be elucidated. In the present study, the expression of RAB38 was analyzed in tumor specimens from patients with non‑small cell lung cancer (NSCLC) with tumor recurrence within 4 years (Group R), and those remaining disease‑free following initial surgery (Group NR), by reverse transcription‑semi‑quantitative PCR and subsequent semi‑quantification using ImageJ v4.0 software. The results revealed that the expression of RAB38 in Group R and NR specimens was positively associated with tumor recurrence; a high expression level was also associated with poor survival rate in these patients. Using NSCLC cell lines, it was demonstrated that tumor cells with mutations in the active epidermal growth factor receptor (EGFR) gene expressed higher levels of RAB38 compared with those with the wild‑type gene by reverse transcription‑PCR and western blot analysis. Furthermore, following specific RAB38 gene knockdown by short hairpin RNA transfection, EGFR mutants exhibited markedly reduced invasiveness when compared with cells transfected with empty vector controls by Matrigel Transwell assays. These results suggest that RAB38 is an important prognostic factor in NSCLC, and may serve a critical role in NSCLC‑associated tumor metastasis.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Hsieh, J., Hou, M., Chang, J.W., Shen, Y., Cheng, H., & Hsu, T. (2019). RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer. Oncology Letters, 18, 2598-2604. https://doi.org/10.3892/ol.2019.10547
MLA
Hsieh, J., Hou, M., Chang, J. W., Shen, Y., Cheng, H., Hsu, T."RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer". Oncology Letters 18.3 (2019): 2598-2604.
Chicago
Hsieh, J., Hou, M., Chang, J. W., Shen, Y., Cheng, H., Hsu, T."RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer". Oncology Letters 18, no. 3 (2019): 2598-2604. https://doi.org/10.3892/ol.2019.10547